8-K

   1
                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K

- --------------------------------------------------------------------------------



                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


         Date of Report (Date of Earliest Event Reported): June 13, 2001



                                 AMEDISYS, INC.
                                 --------------
               (Exact Name of Registrant as Specified in Charter)


                                    Delaware
                         (State or Other Jurisdiction of
                         Incorporation or Organization)


          0-24260                                   11-3131700
          --------                                  ----------
  (Commission File Number)                (I.R.S. Employer Identification No.)


               11100 Mead Road, Suite 300, Baton Rouge, LA 70816
               -------------------------------------------------
          (Address of principal executive offices including zip code)


                                 (225) 292-2031
                                 --------------
              (Registrant's telephone number, including area code)



   2





ITEM 5. OTHER EVENTS

              On June 13, 2001, Amedisys, Inc., "the Company", issued a press
         release attached hereto as Exhibit 99.1 to announce that it has
         overstated net service revenues for the quarters ended December 31,
         2000 and March 31, 2001.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

         (a)  Financial Statements of Business Acquired.

              Not applicable.

         (b)  Pro Forma Financial Information.

              Not applicable.

         (c)  Exhibit
              No.

                                                                          Page
             99.1     (i) Press Release dated June 13, 2001 announcing
                          that the Company has overstated net service
                          revenues for the quarters ended
                          December 31, 2000 and March 31, 2001...........  A-1

                          (i) Filed herewith.




                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

AMEDISYS, INC.

By:   /s/ John M. Joffrion
   --------------------------------------------
John M. Joffrion
Senior Vice President of Finance
Principal Accounting and Financial Officer

DATE: June 14, 2001

EX-99.1

   1
For Immediate Release


                                                                  EXHIBIT 99.1



                               AMEDISYS ANNOUNCES
                        NET SERVICE REVENUE OVERSTATEMENT

BATON ROUGE, Louisiana (June 13, 2001) - Amedisys, Inc. (OTC BB: "AMED") today
announced that it believes that it has overstated its net service revenues for
the quarters ended December 31, 2000 and March 31, 2001.

The implementation of the Prospective Payment System ("PPS") on October 1, 2000
made significant changes to the reimbursement methodology for home health
nursing companies, necessitating changes to systems processing provider and
patient-specific claims for both the intermediary and the individual home health
provider. The Company noted certain discrepancies in these systems which had the
effect of overstating net service revenues. At this time, the Company is
continuing to verify all the data to determine the overall impact upon
previously reported revenues. While the Company has not yet determined the exact
amount, it believes the resulting negative adjustment to net service revenues
could range between $4 and $7 million, to be allocated between the fourth
quarter of 2000 and the first quarter of 2001. The Company expects to report
actual adjustments as soon as possible.

The Company expects to be profitable in the quarter ending June 30, 2001 with
continued growth in revenue and profitability throughout the year.

A conference call has been scheduled for 9:00 a.m. Eastern Time on Thursday,
June 14, 2001, to discuss these issues. The call will be hosted by Bill Borne,
Chief Executive Officer of Amedisys, Inc.

TO PARTICIPATE IN THE CONFERENCE CALL, PLEASE DIAL 800-388-8975 A FEW MINUTES
BEFORE 9:00 A.M. EDT ON JUNE 14, 2001. A REPLAY OF THE CONFERENCE CALL WILL BE
AVAILABLE THROUGH JUNE 21, 2001, BY DIALING 800-428-6051. THE ACCESS CODE IS
#197048 FOR THE REPLAY.

Amedisys, Inc. is a multi-regional provider of home health nursing services and
is headquartered in Baton Rouge, Louisiana. Its common stock trades on the OTC
Bulletin Board under the symbol "AMED".

This press release includes statements that may constitute "forward-looking"
statements, usually containing the words "believe", "estimate", "project",
"expect" or similar expressions. Forward-looking statements inherently involve
risks and uncertainties that could cause actual results to differ materially
from the forward-looking statements. Factors that would cause or contribute to
such differences include, but are not limited to, continued acceptance of the
Company's products and services in the marketplace, competitive factors, changes
in government reimbursement procedures, dependence upon third-party vendors, and
other risks discussed in the Company's periodic filings with the Securities and
Exchange Commission. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or changes
after the date of this release.




   2

    Additional information on this Company can be found on the World Wide Web

                             http://www.amedisys.com

                    For further information, please contact:

             John Joffrion, Senior Vice President at (225) 292-2031
                                       or
    RJ Falkner & Company, Inc., Investor Relations Counsel at (800) 377-9893

                                 or via e-mail

                              at info@rjfalkner.com